|
ZFP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.358710E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.726170E-02 |
| Normal-vs-Stage2 |
1.842380E-01 |
| Normal-vs-Stage3 |
1.491960E-01 |
| Normal-vs-Stage4 |
7.531600E-01 |
| Stage1-vs-Stage2 |
8.386600E-01 |
| Stage1-vs-Stage3 |
8.095800E-01 |
| Stage1-vs-Stage4 |
2.921800E-01 |
| Stage2-vs-Stage3 |
9.939600E-01 |
| Stage2-vs-Stage4 |
2.790800E-01 |
| Stage3-vs-Stage4 |
2.982600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.427500E-04 |
| Normal-vs-AfricanAmerican |
2.449600E-01 |
| Normal-vs-Asian |
3.340800E-01 |
| Caucasian-vs-AfricanAmerican |
9.598400E-02 |
| Caucasian-vs-Asian |
9.184400E-01 |
| AfricanAmerican-vs-Asian |
6.234000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.222390E-02 |
| Normal-vs-Female |
1.001280E-03 |
| Male-vs-Female |
1.058200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.468200E-01 |
| Normal-vs-Extreme_Weight |
2.202600E-01 |
| Normal-vs-Obese |
4.484300E-03 |
| Normal-vs-Extreme_Obese |
3.596400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.146000E-01 |
| Normal_Weight-vs-Obese |
7.248300E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.292800E-01 |
| Extreme_Weight-vs-Obese |
7.936100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.346600E-01 |
| Obese-vs-Extreme_Obese |
7.831800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.853640E-01 |
| Normal-vs-Age(41-60Yrs) |
1.162940E-03 |
| Normal-vs-Age(61-80Yrs) |
2.657600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.328600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.492800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.409000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.702800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.723800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.033800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.222200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.023800E-04 |
| Normal-VS-Type2 PRCC |
3.851000E-01 |
| Normal-VS-KIRP CIMP |
6.666600E-01 |
| Normal-VS-Unclassified PRCC |
2.775800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.930200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.670000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.784400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.677200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.962300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.358400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.040000E-01 |
| Normal-vs-N1 |
6.586200E-02 |
| Normal-vs-N2 |
1.302240E-02 |
| N0-vs-N1 |
2.137400E-01 |
| N0-vs-N2 |
1.830810E-01 |
| N1-vs-N2 |
6.647600E-02 |
|
|
